Gujarat Themis Biosyn Limited — Others, 20-05-2025: Change in Management

Gujarat Themis Biosyn has announced a board meeting on which it approved the audited financial results for the quarter and year ended March 31, 2025. The company recorded total income of ₹39.08 Cr for the quarter and ₹153.23 Cr for the year, with net profit after tax at ₹11.99 Cr quarterly and ₹48.77 Cr annually. The board proposed a final dividend of Re. 0.67 per share, pending shareholder approval. KRS AND Co. was appointed as Secretarial Auditors for five years, while Raja Dutta & Co. will serve as Cost Auditors for FY 2025-26.